Michael Schneck

Efficacy and safety of minimally invasive surgery with thrombolysis in intracerebral haemorrhage evacuation (MISTIE III): a randomised, controlled, open-label, blinded endpoint phase 3 trial

Daniel F. Hanley, Richard E. Thompson, Michael Rosenblum et al. · The Lancet · 2019 · 850 citations · Full text

Thrombosis, Endpoint Phase 3, Interventional Neuroradiology +12

Deferoxamine mesylate in patients with intracerebral haemorrhage (i-DEF): a multicentre, randomised, placebo-controlled, double-blind phase 2 trial

Magdy Selim, Lydia D. Foster, Claudia S. Moy et al. · The Lancet Neurology · 2019 · 239 citations · Full text

Thrombosis, Reperfusion Injury, Deferoxamine Mesylate +11

The Future of Neurology

José Biller, Michael Schneck · Frontiers in Neurology · 2011 · 144 citations · Full text

Cognitive Science, Neural Science, Neuroengineering +15

Venous thromboembolism: deep venous thrombosis and pulmonary embolism in a neurosurgical population

Ahmad Khaldi, Naseem Helo, Michael Schneck et al. · Journal of neurosurgery · 2010 · 140 citations

Stroke Prevention in Symptomatic Large Artery Intracranial Atherosclerosis Practice Advisory

Tanya N. Turan, Osama O. Zaidat, Gary Gronseth et al. · Neurology · 2022 · 80 citations · Full text

Cerebrovascular Disease, Pharmacotherapy, Thrombosis +17